Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?

Por Imyanitov Evgeny N
Publicado em 2009-04-01

Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?

Por Imyanitov, Evgeny N
Publicado em 2009

Systemic therapy for hereditary cancer

Por Imyanitov, Evgeny N
Publicado em 2012

Systemic treatment for hereditary cancers: a 2012 update

Por Imyanitov, Evgeny N, Byrski, Tomasz
Publicado em 2013

Drug therapy for hereditary cancers

Por Imyanitov, Evgeny N, Moiseyenko, Vladimir M
Publicado em 2011

Bardet-Biedl Syndrome

Por Suspitsin, Evgeny N., Imyanitov, Evgeny N.
Publicado no Mol Syndromol (2016)

Cytotoxic and targeted therapy for hereditary cancers

Por Iyevleva, Aglaya G., Imyanitov, Evgeny N.
Publicado no Hered Cancer Clin Pract (2016)

EVALUATING CANCER EPIDEMIOLOGIC RISK FACTORS USING MULTIPLE PRIMARY MALIGNANCIES

Por Kuligina, Ekatherina, Reiner, Anne, Imyanitov, Evgeny N., Begg, Colin B.
Publicado em 2010

Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer

Por Berstein, Lev M, Iyevleva, Aglaya G, Vasilyev, Dmitry, Poroshina, Tatyana E, Imyanitov, Evgeny N
Publicado em 2013

Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7

Por Suspitsin, Evgeny N., Sokolenko, Anna P., Lyazina, Lydia V., Preobrazhenskaya, Elena V., Lepenchuk, Alla Y., Imyanitov, Evgeny N.
Publicado no Mol Syndromol (2015)

Unusual Clinical Presentation of Gastrointestinal Clear Cell Sarcoma

Por Raskin, Grigory A., Pozharisski, Kazimir M., Iyevleva, Aglaya G., Rikov, Ivan V., Orlova, Rashida V., Imyanitov, Evgeny N.
Publicado no Gastrointest Tumors (2015)

BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine

Por Gu, Yuexi, Helenius, Mikko, Väänänen, Kristiina, Bulanova, Daria, Saarela, Jani, Sokolenko, Anna, Martens, John, Imyanitov, Evgeny, Kuznetsov, Sergey
Publicado no Sci Rep (2016)

The role of intradermal proliferation of T-cells in the pathogenesis of psoriasis

Por Khairutdinov, Vladislav R., Mikhailichenko, Anastasiya F., Belousova, Irena E., Kuligina, Ekatherina Sh., Samtsov, Alexey V., Imyanitov, Evgeny N.
Publicado no An Bras Dermatol (2017)

PALB2 mutations in German and Russian patients with bilateral breast cancer

Por Bogdanova, Natalia, Sokolenko, Anna P., Iyevleva, Aglaya G., Abysheva, Svetlana N., Blaut, Magda, Bremer, Michael, Christiansen, Hans, Rave-Fränk, Margret, Dörk, Thilo, Imyanitov, Evgeny N.
Publicado em 2010

BRCA1 4153delA founder mutation in Russian ovarian cancer patients

Por Krylova Nadezhda, Lobeiko Oksana S, Sokolenko Anna P, Iyevleva Aglaya G, Rozanov Maxim E, Mitiushkina Natalia V, Gergova Madina M, Porhanova Tatiana V, Urmancheyeva Adel F, Maximov Sergey, Togo Alexandr V, Imyanitov Evgeny N
Publicado em 2006-09-01

CHEK2 1100 delC mutation in Russian ovarian cancer patients

Por Krylova, Nadezhda Yu, Ponomariova, Daria N, Sherina, Natalia Yu, Ogorodnikova, Natalia Yu, Logvinov, Denis A, Porhanova, Natalia V, Lobeiko, Oksana S, Urmancheyeva, Adel F, Maximov, Sergey Ya, Togo, Alexandr V, Suspitsin, Evgeny N, Imyanitov, Evgeny N
Publicado em 2007

BRCA1 4153delA founder mutation in Russian ovarian cancer patients

Por Krylova, Nadezhda Yu, Lobeiko, Oksana S, Sokolenko, Anna P, Iyevleva, Aglaya G, Rozanov, Maxim E, Mitiushkina, Natalia V, Gergova, Madina M, Porhanova, Tatiana V, Urmancheyeva, Adel F, Maximov, Sergey Ya, Togo, Alexandr V, Imyanitov, Evgeny N
Publicado em 2006

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

Por Suspitsin Evgeny N, Sherina Nathalia, Ponomariova Daria N, Sokolenko Anna P, Iyevleva Aglaya G, Gorodnova Tatyana V, Zaitseva Olga A, Yatsuk Olga S, Togo Alexandr V, Tkachenko Nathalia N, Shiyanov Grigory A, Lobeiko Oksana S, Krylova Nadezhda, Matsko Dmitry E, Maximov Sergey, Urmancheyeva Adel F, Porhanova Nathalia V, Imyanitov Evgeny N
Publicado em 2009-02-01

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing

Por Sokolenko, Anna P, Voskresenskiy, Dmitry A, Iyevleva, Aglaya G, Bit-Sava, Elena M, Gutkina, Nadezhda I, Anisimenko, Maxim S, Yu Sherina, Nathalia, Mitiushkina, Nathalia V, Ulibina, Yulia M, Yatsuk, Olga S, Zaitseva, Olga A, Suspitsin, Evgeny N, Togo, Alexandr V, Pospelov, Valery A, Kovalenko, Sergey P, Semiglazov, Vladimir F, Imyanitov, Evgeny N
Publicado em 2009

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

Por Suspitsin, Evgeny N, Sherina, Nathalia Yu, Ponomariova, Daria N, Sokolenko, Anna P, Iyevleva, Aglaya G, Gorodnova, Tatyana V, Zaitseva, Olga A, Yatsuk, Olga S, Togo, Alexandr V, Tkachenko, Nathalia N, Shiyanov, Grigory A, Lobeiko, Oksana S, Krylova, Nadezhda Yu, Matsko, Dmitry E, Maximov, Sergey Ya, Urmancheyeva, Adel F, Porhanova, Nathalia V, Imyanitov, Evgeny N
Publicado em 2009